page 1
page 2
page 3
page 4
page 5
page 6
page 7
page 8
page 9
page 10
page 11
page 12
page 13
page 14
page 15
page 16
page 17
page 18
page 19
page 20
page 21
page 22
page 23
page 24
page 25
page 26
page 27
page 28
page 29
page 30
page 31
page 32
page 33
page 34
page 35
page 36
page 37
page 38
page 39
page 40
page 41
page 42
page 43
page 44
page 45
page 46
page 47
page 48
page 49
page 50
page 51
page 52
page 53
page 54
page 55
page 56
page 57
page 58
page 59
page 60
page 61
page 62
page 63
page 64
page 65
page 66
page 67
page 68
page 69
page 70
page 71
page 72
page 73
page 74
page 75
page 76
page 77
page 78
page 79

70Spire Healthcare Annual Review 2010Spire Healthcare Limited PartnershipNotes to the financial statementsFor the year ended 31 December 201025. Financial risk management continuedFair value hierarchyThe Group uses the following hierarchy for determining and disclosing the fair value of financial instruments by valuation technique:Level 1: quoted (unadjusted) prices in active markets for identical assets or liabilities;Level 2: other techniques for which all inputs which have a significant effect on the recorded fair value are observable, either directly or indirectly; and Level 3: techniques which use inputs which have a significant effect on the recorded fair value that are not based on observable market data.As at 31 December 2010, the Group held the following financial instruments measured at fair value:Liabilities measured at fair value 31 December 2010£000Level 1£000Level 2£000Level 3£000Financial liabilities at fair value through profit and lossInterest rate cap and floor(1,085) - (1,085) - Financial liabilities at fair value using hedge accountingInterest rate swaps210,615 - 210,615 - 209,530 - 209,530 - During the reporting period ending 31 December 2010, there were no transfers between Levels 1 to 3 fair value measurements.As at 31 December 2009, the Group held the following financial instruments measured at fair value:Liabilities measured at fair value 31 December 2009£000Level 1£000Level 2£000Level 3£000Financial liabilities at fair value through profit and lossInterest rate cap and floor4,490 - 4,490 - Financial liabilities at fair value using hedge accountingInterest rate swaps170,872 - 170,872 - 175,362 - 175,362 - During the reporting period ending 31 December 2009, there were no transfers between Levels 1 to 3 fair value measurements.

71Spire Healthcare Limited PartnershipMarket riskMarket risk is the risk that changes in market prices, such as interest rates, will affect the Group's income or the value of its holdings of financial instruments. The objective of market risk management is to manage and control market risk exposures within acceptable parameters, while optimising the return on risk.In the opinion of the General Partner the carrying value of the financial instruments is approximately equal to their fair value, except for floating rate debt which is after the deduction of £33 million (2009: £42 million) of issue costs.. Interest rate riskThe Group is exposed to interest rate risk arising from fluctuations in market rates. This affects future cash flows from money market investments and the cost of floating rate borrowings. As at 31 December 2010, 89% of the Group's borrowings were hedged by interest rate swaps and the cap, although the cap did not qualify for hedge accounting. Money market investments, held at floating rates of interest, represented 3% of total assets held by the Group.Generally the Group seeks to apply hedge accounting in order to manage volatility in the Income Statement.The Group has entered into a number of interest rate swaps in order to fix the interest payable on its bank loans, therefore minimising its exposure to interest rate risk.Interest rates on variable rate loans are determined by LIBOR fixings on a quarterly basis. Interest is settled on all loans in line with agreements and is settled at least annually.Variable£000Fixed £000Total£000Undrawn facility£00031 December 2010141,200 1,163,500 1,304,700 48,400 Effective interest rate3.19%7.67%7.18%31 December 2009152,300 1,163,500 1,315,800 52,375 Effective interest rate5.31%7.72%7.51%The following derivative contracts were in place at 31 December 2010:Interest rateMaturity dateNotional amount£000Carrying value£000Interest rate cap 2.00%October 2013105,000 (1,085)Interest rate swaps5.9735%August 20171,018,500 209,770 Interest rate swaps4.9950%April 201140,000 845 209,530 The following derivative contracts were in place at 31 December 2009:Interest rateMaturity dateNotional amount£000Carrying value£000Interest rate cap and floor6%-5%October 2010105,000 4,490 Interest rate swaps5.9735%August 20171,018,500 168,598 Interest rate swaps4.9950%April 201140,000 2,274 175,362